Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised Controlled Study of Fundoplication or Medical Treatment for Gastro-Oesophageal Reflux in Children
ISRCTN ISRCTN82683558
ClinicalTrials.gov identifier
Public title Randomised Controlled Study of Fundoplication or Medical Treatment for Gastro-Oesophageal Reflux in Children
Scientific title
Acronym N/A
Serial number at source RHC22029
Study hypothesis To measure the effectiveness of fundoplication compared to medical managements in a randomised study of children with severe gastro-oesophageal reflux and thus develop management strategies for the appropriate and cost-effective treatment of children with gastro-oesophageal reflux.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Digestive system diseases: Other digestive system disease
Participants - inclusion criteria Children aged less than 16 years with clinical evidence of gastro-oesophageal reflux. Phase One - 250 to 330. Phase Two - 115 to 125.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/10/2000
Anticipated end date 01/10/2003
Status of trial Completed
Patient information material
Target number of participants 455
Interventions Fundoplication vs medical managements
Primary outcome measure(s) Body weight Z scores.
Secondary outcome measure(s) 1. Continuing or recurrent gastro-oesophageal reflux
2. Complication rate after fundoplication, ECA on EGG
3. Validated quality of life score for patients and parents
Sources of funding NHS Executive North West (UK)
Trial website
Publications
Contact name Dr  David  Lloyd
  Address Royal Liverpool Children's Hospital NHS Trust
Professor of Paediatric Surgery
Institute of Child Health, Eaton Road
Eaton Road
  City/town Liverpool
  Zip/Postcode L12 2AP
  Country United Kingdom
  Tel +44 (0)151 252 5250
  Fax +44 (0)151 252 2024
  Email
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 15/08/2011
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central